Mankind Pharma Ltd (MANKIND) - Total Liabilities

Latest as of June 2026: Rs-165.61 Billion INR ≈ $-1.79 Billion USD

Based on the latest financial reports, Mankind Pharma Ltd (MANKIND) has total liabilities worth Rs-165.61 Billion INR (≈ $-1.79 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Mankind Pharma Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Mankind Pharma Ltd - Total Liabilities Trend (2019–2026)

This chart illustrates how Mankind Pharma Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see MANKIND total assets.

Mankind Pharma Ltd Competitors by Total Liabilities

The table below lists competitors of Mankind Pharma Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Banco Santander (Brasil) S.A. SA:SANB3	Brazil	R$1.14 Trillion
Chongqing Sokon Ind Grp Co SHG:601127	China	CN¥92.78 Billion
Tempus AI, Inc. Class A Common Stock NASDAQ:TEM	USA	$1.92 Billion
WOORI FIN. GRP SP.ADR/3 F:2WGA	Germany	€563.60 Trillion
Sanmina Corporation NASDAQ:SANM	USA	$6.98 Billion
Elanco Animal Health NYSE:ELAN	USA	$6.97 Billion
CSPC PHARMACEUT.GR. ADR4 F:CVGU	Germany	€12.15 Billion
REXEL S.A. ADR EO 5 F:E7V0	Germany	€8.96 Billion

Liability Composition Analysis (2019–2026)

This chart breaks down Mankind Pharma Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Mankind Pharma Ltd (MANKIND) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	N/A	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.00	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	N/A	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mankind Pharma Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mankind Pharma Ltd (2019–2026)

The table below shows the annual total liabilities of Mankind Pharma Ltd from 2019 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs115.18 Billion ≈ $1.25 Billion	-12.68%
2025-03-31	Rs131.91 Billion ≈ $1.43 Billion	+452.53%
2024-03-31	Rs23.87 Billion ≈ $258.20 Million	+15.52%
2023-03-31	Rs20.67 Billion ≈ $223.50 Million	-27.01%
2022-03-31	Rs28.31 Billion ≈ $306.21 Million	+87.54%
2021-03-31	Rs15.10 Billion ≈ $163.27 Million	+7.71%
2020-03-31	Rs14.02 Billion ≈ $151.59 Million	+23.96%
2019-03-31	Rs11.31 Billion ≈ $122.29 Million	--

About Mankind Pharma Ltd

NSE:MANKIND India Drug Manufacturers - Specialty & Generic

Market Cap

$11.06 Billion

Rs1.02 Trillion INR

Market Cap Rank

#2063 Global

#83 in India

Share Price

Rs2474.90

Change (1 day)

-1.00%

52-Week Range

Rs1927.40 - Rs2617.90

All Time High

Rs2998.40